UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009068
Receipt number R000010613
Scientific Title Assessment of validity and safety in Enoxaparin administration soon after cesarean section.
Date of disclosure of the study information 2012/10/09
Last modified on 2014/03/25 11:43:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Assessment of validity and safety in Enoxaparin administration soon after cesarean section.

Acronym

Clinical assessment of Enoxaparin administration soon after cesarean section.

Scientific Title

Assessment of validity and safety in Enoxaparin administration soon after cesarean section.

Scientific Title:Acronym

Clinical assessment of Enoxaparin administration soon after cesarean section.

Region

Japan


Condition

Condition

venous thromboembolism (VTE)

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate if the prevention against venous thromboembolism after cesarean section by Enoxaparin administration has less adverse and more preferable effects compared to non-fractional heparin.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The incidence rate of VTE and other complications following cesarean section.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

administrated group of unfractionated heparin calcium (Mochida)

Interventions/Control_2

administrated group of Enoxaparin (Clexane)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Women who delivered a baby/babies by cesarean section.

Key exclusion criteria

thrombocytopenia,
acute bacterial endocarditis
renal dysfunction (creatinine clearance less than 50 mL/min)

Target sample size

160


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroaki Itoh

Organization

Hamamatsu University School of Medicine

Division name

Obstetrics and Gynecology

Zip code


Address

1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka, Japan

TEL

053-435-2309

Email

hitou-endo@umin.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroaki Itoh

Organization

Hamamatsu University School of Medicine

Division name

Obstetrics and Gynecology

Zip code


Address

1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka

TEL

053-435-2309

Homepage URL


Email

hitou-endo@umin.ac.jp


Sponsor or person

Institute

Obstetrics and Gynecology, Hamamatsu University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Obstetrics and Gynecology, Hamamatsu University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

浜松医科大学医学部付属病院(静岡県)


Other administrative information

Date of disclosure of the study information

2012 Year 10 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2012 Year 08 Month 31 Day

Date of IRB


Anticipated trial start date

2012 Year 10 Month 09 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 10 Month 09 Day

Last modified on

2014 Year 03 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010613


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name